Your browser doesn't support javascript.
Clinicopathological Features and Outcome of COVID-19-Early Experiences from Three COVID Hospitals, Chittagong, Bangladesh
JOURNAL OF THE SCIENTIFIC SOCIETY ; 48(3):156-160, 2021.
Article in English | Web of Science | ID: covidwho-1911872
ABSTRACT

Introduction:

COVID 19 is an unknown virus affecting mankind creating a deadly experience to all. It is true for Bangladesh also. So the objectives of the present study are to find the clinicopathological features and outcome of COVID patients admitted to three COVID dedicated hospitals of Chittagong, Bangladesh.

Methods:

This was an observational study where a total of 209 patients admitted to three COVID dedicated hospital were recruited. Clinicopathological data were recorded and patients were under observation till discharge and thus outcome were recorded. Prior consent was taken from the patients and ethical clearance was also taken. Data were compiled and analyzed by Statistical Package for Social Sciences-20.

Results:

Among 209 patients most of them were male 139 (66.5%) and male to female ratio was 1.981. Age group distribution revealed more were aggregated in the age group of 41-50 years 36 (17.2%), 51-60 years 54 (25.8%), and 61-70 years 57 (27.3%). Among all 92 (44%) patients were reverse transcription-polymerase chain reaction (RT-PCR) positive and 117 (56%) were probable cases. Fever was present in 195 (93.3%) cases, cough in 180 (86.1%), respiratory distress in 105 (50.2%) anosmia in 123 (58.8%), aguesea in 112 (53.58%) and lethargy was present in 143 (68.42%). Chest X-ray findings revealed 73 (34.9%) had bilateral patchy opacities, 20 (9.6%) had unilateral opacities 65 (31.1%) had consolidations, 6 (2.9%) had ground glass opacities, and 2 (1.0%) had pleural effusion. Supplemental O2 was given in 173 (82.8%) patients, Favipiravir in 59 (28.2%), Remdesivir in 111 (53.1%), Methylprednisolone in 87 (41.6%), Dexamethasone in 93 (44.5%), Antibiotics in 204 (97.60%), Toccilizumab in 34 (16.3%), plasma in 18 (8.6%), and low molecular weight heparin (LMWH) in 200 (95.7%) patients. Regarding outcome of the COVID patients admitted, 85 (92.4%) patients improved, 6 (6.5%) died who were RT-PCR positive and 107 (91.15%) improved, 9 (7.7%) died who were probable cases. Total death rate was 7.1%.

Conclusion:

The present study findings were some early activities among COVID patients in the years 2020. Male were more affected and middle age group people were the most victims.
Keywords

Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Prognostic study / Qualitative research Language: English Journal: JOURNAL OF THE SCIENTIFIC SOCIETY Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Prognostic study / Qualitative research Language: English Journal: JOURNAL OF THE SCIENTIFIC SOCIETY Year: 2021 Document Type: Article